Artelo Biosciences, Inc.
ARTLNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $825.65K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.19$19.91
- Volume (live)
- -
- Avg. volume (3M)
- 946.24K
Artelo Biosciences (ARTL) Stock Price & Financial Analysis
Artelo Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.70 - $2.76 |
|---|---|
| 52-Week High | $19.91 |
| 52-Week Low | $1.19 |
| Open | $2.75 |
| Volume (last close) | 12.30K |
| Average Volume (3M) | 946.24K |
| 50-Day MA | $5.29 |
|---|---|
| 200-Day MA | $5.81 |
| 1-Year Change | −34.61% |
| Market Cap | 825.65K |
|---|---|
| Shares Outstanding | 301.33K |
| Price to Book (P/B) | 0.17 |
| EV/EBITDA | 0.28 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Artelo Biosciences at a Glance
As of the Oct 16, 2026 close, Artelo Biosciences (ARTL) has a market capitalization of $825.65K.
As of its latest reported balance sheet, it holds $4.20M in cash and securities against $49.00K of debt, a net cash position of $4.15M.
Artelo Biosciences does not currently pay a dividend.
The share price is down 34.6% over the past year. At $2.70 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.19 to $19.91, below its 200-day moving average of $5.81.
Frequently Asked Questions About Artelo Biosciences
What is the current stock price for ARTL?
As of the Oct 16, 2026 close, ARTL stock trades at $2.70. The 52-week range is $1.19–$19.91, with a day range of $2.70–$2.76.
What is the P/E ratio for ARTL?
The P/E ratio (Price-to-Earnings) for ARTL is shown in the Key Statistics section. This valuation metric helps compare Artelo Biosciences, Inc. to industry peers.
Does ARTL pay dividends?
Artelo Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARTL?
Analyst ratings and recommendations for ARTL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ARTL?
As of the Oct 16, 2026 close, Artelo Biosciences's market capitalization is $813,599.1, classifying it as a micro-cap company. Artelo Biosciences operates in the Healthcare sector within the Biotechnology industry.